View in EDS

Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects.

Saved in:
Bibliographic Details
Title: Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects.
Authors: Kaldjob-Heinrich L; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany., Nuciforo S; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Clinic of Gastroenterology and Hepatology, Clarunis University Center for Gastrointestinal and Liver Diseases Basel, Basel, Switzerland., Lemke S; Quantitative Biology Center (QBiC), Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany., Stahl A; NMI, Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany., Czemmel S; Quantitative Biology Center (QBiC), Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany., Babaei S; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany., Blukacz L; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland., Meier MA; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Clinic of Gastroenterology and Hepatology, Clarunis University Center for Gastrointestinal and Liver Diseases Basel, Basel, Switzerland., Zhang Y; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany., Schürch CM; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany., Gonzalez-Menendez I; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany., Woelffing P; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Department of Medical Oncology and Pneumology, Eberhard-Karls University, Tuebingen, Germany., Malek NP; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tuebingen, Germany., Scheble V; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany., Nahnsen S; Quantitative Biology Center (QBiC), Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany., Claassen M; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.; Department of Computer Science, University of Tübingen, Tübingen, Germany.; Machine Learning in Science, Excellence Cluster Machine Learning, University of Tübingen, Tübingen, Germany., Templin M; NMI, Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany., Bösmüller H; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany., Heim MH; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Clinic of Gastroenterology and Hepatology, Clarunis University Center for Gastrointestinal and Liver Diseases Basel, Basel, Switzerland., Dauch D; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Department of Medical Oncology and Pneumology, Eberhard-Karls University, Tuebingen, Germany., Bitzer M; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tuebingen, Germany.
Source: Gastro hep advances [Gastro Hep Adv] 2024 Nov 20; Vol. 4 (3), pp. 100590. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc on behalf of the AGA Institute Country of Publication: Netherlands NLM ID: 9918350485906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-5723 (Electronic) Linking ISSN: 27725723 NLM ISO Abbreviation: Gastro Hep Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39911497
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kaldjob-Heinrich+L%22">Kaldjob-Heinrich L</searchLink>; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Nuciforo+S%22">Nuciforo S</searchLink>; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Clinic of Gastroenterology and Hepatology, Clarunis University Center for Gastrointestinal and Liver Diseases Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lemke+S%22">Lemke S</searchLink>; Quantitative Biology Center (QBiC), Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Stahl+A%22">Stahl A</searchLink>; NMI, Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Czemmel+S%22">Czemmel S</searchLink>; Quantitative Biology Center (QBiC), Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Babaei+S%22">Babaei S</searchLink>; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Blukacz+L%22">Blukacz L</searchLink>; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Meier+MA%22">Meier MA</searchLink>; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Clinic of Gastroenterology and Hepatology, Clarunis University Center for Gastrointestinal and Liver Diseases Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schürch+CM%22">Schürch CM</searchLink>; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Menendez+I%22">Gonzalez-Menendez I</searchLink>; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Woelffing+P%22">Woelffing P</searchLink>; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Department of Medical Oncology and Pneumology, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Malek+NP%22">Malek NP</searchLink>; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Scheble+V%22">Scheble V</searchLink>; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Nahnsen+S%22">Nahnsen S</searchLink>; Quantitative Biology Center (QBiC), Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Claassen+M%22">Claassen M</searchLink>; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.; Department of Computer Science, University of Tübingen, Tübingen, Germany.; Machine Learning in Science, Excellence Cluster Machine Learning, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Templin+M%22">Templin M</searchLink>; NMI, Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bösmüller+H%22">Bösmüller H</searchLink>; Department of Pathology and Neuropathology, Eberhard Karls University, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Heim+MH%22">Heim MH</searchLink>; Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Clinic of Gastroenterology and Hepatology, Clarunis University Center for Gastrointestinal and Liver Diseases Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dauch+D%22">Dauch D</searchLink>; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Department of Medical Oncology and Pneumology, Eberhard-Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bitzer+M%22">Bitzer M</searchLink>; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tuebingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard-Karls University, Tuebingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tuebingen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918350485906676%22">Gastro hep advances</searchLink> [Gastro Hep Adv] 2024 Nov 20; Vol. 4 (3), pp. 100590. <i>Date of Electronic Publication: </i>2024 Nov 20 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc+on+behalf+of+the+AGA+Institute%22">Elsevier Inc on behalf of the AGA Institute </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9918350485906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2772-5723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227725723%22">27725723 </searchLink><i>NLM ISO Abbreviation: </i>Gastro Hep Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39911497
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.gastha.2024.11.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100590
    Titles:
      – TitleFull: Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kaldjob-Heinrich L
      – PersonEntity:
          Name:
            NameFull: Nuciforo S
      – PersonEntity:
          Name:
            NameFull: Lemke S
      – PersonEntity:
          Name:
            NameFull: Stahl A
      – PersonEntity:
          Name:
            NameFull: Czemmel S
      – PersonEntity:
          Name:
            NameFull: Babaei S
      – PersonEntity:
          Name:
            NameFull: Blukacz L
      – PersonEntity:
          Name:
            NameFull: Meier MA
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Schürch CM
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Menendez I
      – PersonEntity:
          Name:
            NameFull: Woelffing P
      – PersonEntity:
          Name:
            NameFull: Malek NP
      – PersonEntity:
          Name:
            NameFull: Scheble V
      – PersonEntity:
          Name:
            NameFull: Nahnsen S
      – PersonEntity:
          Name:
            NameFull: Claassen M
      – PersonEntity:
          Name:
            NameFull: Templin M
      – PersonEntity:
          Name:
            NameFull: Bösmüller H
      – PersonEntity:
          Name:
            NameFull: Heim MH
      – PersonEntity:
          Name:
            NameFull: Dauch D
      – PersonEntity:
          Name:
            NameFull: Bitzer M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 11
              Text: 2024 Nov 20
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2772-5723
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Gastro hep advances
              Type: main
ResultId 1